loadpatents
name:-0.050774812698364
name:-0.042322874069214
name:-0.008328914642334
CLOZEL; Martine Patent Filings

CLOZEL; Martine

Patent Applications and Registrations

Patent applications and USPTO patent grants for CLOZEL; Martine.The latest application filed is for "combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases".

Company Profile
7.40.49
  • CLOZEL; Martine - Allschwil CH
  • Clozel; Martine - Binningen CH
  • CLOZEL; Martine - Binnigen CH
  • Clozel; Martine - CH-4102 Binningen FR
  • Clozel; Martine - Benningen FR
  • Clozel; Martine - Saint-Louis FR
  • Clozel; Martine - Winterhalde CH
  • Clozel; Martine - St. Louis FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Combinations Of A 4-pyrimidinesulfamide Derivative With Active Ingredients For The Treatment Of Endothelin Related Diseases
App 20220064149 - BELLET; Marc ;   et al.
2022-03-03
Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases
Grant 11,174,247 - Bellet , et al. November 16, 2
2021-11-16
Pharmaceutical Combination Comprising A Selective S1p1 Receptor Agonist
App 20210338640 - CLOZEL; Martine ;   et al.
2021-11-04
Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases
Grant 11,155,535 - Bellet , et al. October 26, 2
2021-10-26
Therapeutic Compositions
App 20210177849 - Clozel; Martine
2021-06-17
Pharmaceutical combination comprising a selective S1P1 receptor agonist
Grant 11,026,927 - Clozel , et al. June 8, 2
2021-06-08
Therapeutic Compositions
App 20200352944 - Clozel; Martine
2020-11-12
Pharmaceutical Combination Comprising Ponesimod
App 20200069655 - CLOZEL; Martine ;   et al.
2020-03-05
Combinations Of A 4-pyrimidinesulfamide Derivative With Active Ingredients For The Treatment Of Endothelin Related Diseases
App 20200061061 - BELLET; Marc ;   et al.
2020-02-27
Therapeutic Compositions
App 20200038401 - Clozel; Martine
2020-02-06
Pharmaceutical Combination Comprising A Selective S1p1 Receptor Agonist
App 20190175563 - CLOZEL; Martine ;   et al.
2019-06-13
Pharmaceutical combination comprising a selective S1P1 receptor agonist
Grant 10,245,253 - Clozel , et al.
2019-04-02
Therapeutic Compositions
App 20190083494 - Clozel; Martine
2019-03-21
Therapeutic Compositions
App 20180147205 - CLOZEL; Martine
2018-05-31
Pharmaceutical Combination Comprising A Selective S1p1 Receptor Agonist
App 20170348287 - CLOZEL; Martine ;   et al.
2017-12-07
Therapeutic compositions containing macitentan
Grant 9,597,331 - Clozel March 21, 2
2017-03-21
Therapeutic Compositions Containing Macitentan
App 20160022678 - CLOZEL; Martine
2016-01-28
Therapeutic Compositions Containing Macitentan
App 20140329824 - CLOZEL; MARTINE
2014-11-06
Therapeutic compositions containing macitentan
Grant 8,809,334 - Clozel August 19, 2
2014-08-19
Therapeutic Compositions
App 20140148460 - CLOZEL; Martine
2014-05-29
Combination Comprising Paclitaxel For Treating Ovarian Cancer
App 20130317048 - Clozel; Martine ;   et al.
2013-11-28
Combination comprising macitentan and paclitaxel for treating multi-drug resistant ovarian cancer
Grant 8,541,433 - Clozel , et al. September 24, 2
2013-09-24
Therapeutic Compositions
App 20130210830 - CLOZEL; Martine
2013-08-15
Therapeutic Compositions
App 20130005734 - CLOZEL; Martine
2013-01-03
Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitor
Grant 8,268,847 - Clozel September 18, 2
2012-09-18
Therapeutic Compositions Containing Macitentan
App 20110136818 - Clozel; Martine
2011-06-09
Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseases
Grant 7,868,012 - Bolli , et al. January 11, 2
2011-01-11
Combination Comprising Paclitaxel for Treating Ovarian Cancer
App 20100311774 - Clozel; Martine ;   et al.
2010-12-09
Substituted 1,2,3,4-tetrahydroisoquinoline Derivatives
App 20100256182 - Aissaoui; Hamed ;   et al.
2010-10-07
Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
Grant 7,763,638 - Aissaoui , et al. July 27, 2
2010-07-27
Pyridine derivatives
Grant 7,750,161 - Bur , et al. July 6, 2
2010-07-06
Thiophene derivatives
Grant 7,750,040 - Bolli , et al. July 6, 2
2010-07-06
Endothelin Receptor Antagonists For Early Stage Idiopathic Pulmonary Fibrosis
App 20100022568 - Clozel; Martine ;   et al.
2010-01-28
Therapeutic Compositions Comprising a Specific Endothelin Receptor Antagonist and a PDE5 Inhibitor
App 20090318459 - Clozel; Martine
2009-12-24
Quinoxalin-3-one derivatives as orexin receptor antagonists
Grant 7,538,109 - Aissaoui , et al. May 26, 2
2009-05-26
Pyrimidine-sulfamides and their use as endothelian receptor antagonist
Grant 7,452,896 - Bolli , et al. November 18, 2
2008-11-18
Sulfonylamino-acetic acid derivatives
Grant 7,435,815 - Aissaoui , et al. October 14, 2
2008-10-14
Quinoline derivatives
Grant 7,375,227 - Aissaoui , et al. May 20, 2
2008-05-20
Novel Thiophene Derivatives
App 20080064740 - Bolli; Martin ;   et al.
2008-03-13
Alkansulfonamides as endothelin antagonists
Grant 7,323,465 - Bolli , et al. January 29, 2
2008-01-29
Sulfamides as Endothelin Receptor Antagonists for the Treatment of Cardiovascular Diseases
App 20080004298 - Bolli; Martin ;   et al.
2008-01-03
Sulfamides and their use as endothelin receptor antagonists
Grant 7,285,549 - Bolli , et al. October 23, 2
2007-10-23
Sulfonylamino-acetic Acid Derivatives
App 20070244156 - Aissaoui; Hamed ;   et al.
2007-10-18
Sulfonylamino-acetic acid derivatives
Grant 7,279,578 - Aissaoui , et al. October 9, 2
2007-10-09
Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
App 20070191424 - Aissaoui; Hamed ;   et al.
2007-08-16
Novel sulfamides
App 20070167472 - Bolli; Martin ;   et al.
2007-07-19
Benzo-fused heterocycles as endothelin antagonists
Grant 7,238,685 - Bolli , et al. July 3, 2
2007-07-03
Benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
Grant 7,192,950 - Aissaoui , et al. March 20, 2
2007-03-20
Novel pyridine derivatives
App 20070043081 - Bur; Daniel ;   et al.
2007-02-22
Quinoxalinone-3-one derivatives as orexin receptor antagonists
App 20070027157 - Aissaoui; Hamed ;   et al.
2007-02-01
Novel piperidine derivatives
App 20070010516 - Aissaoui; Hamed ;   et al.
2007-01-11
Piperazine-alkyl-ureido derivatives
App 20060211707 - Aissaoui; Hamed ;   et al.
2006-09-21
Sulfamides and their use as endothelin receptor antagonists
Grant 7,094,781 - Bolli , et al. August 22, 2
2006-08-22
Arylalkane-sulfonamides having endothelin-antagonist activity
Grant 7,091,201 - Weller , et al. August 15, 2
2006-08-15
Novel sulfamides
App 20060178365 - Bolli; Martin ;   et al.
2006-08-10
Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists
App 20060178515 - Aissaoui; Hamed ;   et al.
2006-08-10
7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives
Grant 7,067,519 - Aissaoui , et al. June 27, 2
2006-06-27
1-Pyridin-4-yl-urea derivatives
App 20060094716 - Aissaoui; Hamed ;   et al.
2006-05-04
Sulfonylamino-acetic acid derivatives
App 20060014783 - Aissaoui; Hamed ;   et al.
2006-01-19
Arylethene-sulfonamides
Grant 6,951,856 - Boss , et al. October 4, 2
2005-10-04
Novel benzo-fused heterocycles as endothelin antagonisits
App 20050124605 - Bolli, Martin ;   et al.
2005-06-09
Novel alkansulfonamides as endothelin antagonists
App 20050085639 - Bolli, Martin ;   et al.
2005-04-21
4-(Piperidyl-and pyrrolidyl-alkyl-ureido)-quinolines as urotensin II receptor antagonists
App 20050043535 - Aissaoui, Hamed ;   et al.
2005-02-24
7 8 9 10-tetrahydro-6h-azepino, 6 7 8 9-tetrahydro-pyrido and 2 3-dihydro-2h-pyrrolo[2 1-b]-quinazolinone derivates
App 20050009852 - Aissaoui, Hamed ;   et al.
2005-01-13
1,2,3,4-tetrahydroisoquinolines derivatives
App 20040242564 - Velker, Jorg ;   et al.
2004-12-02
1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
Grant 6,815,451 - Velker , et al. November 9, 2
2004-11-09
1 2 3 4 Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
App 20040110744 - Velker, Jorg ;   et al.
2004-06-10
Arylalkane-sulfonamides having endothelin-antagonist activity
App 20040102464 - Weller, Thomas ;   et al.
2004-05-27
Novel sulfamides and their use as endothelin receptor antagonists
App 20040077670 - Bolli, Martin ;   et al.
2004-04-22
Butyne diol derivatives
Grant 6,720,322 - Bolli , et al. April 13, 2
2004-04-13
Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
App 20040058912 - Aissaoui, Hamed ;   et al.
2004-03-25
1,2,3,4-tetrahydroisoquinoline derivatives
Grant 6,703,392 - Aissaoui , et al. March 9, 2
2004-03-09
Novel arylethene-sulfonamides
App 20030220359 - Boss, Christoph ;   et al.
2003-11-27
1,2,3,4-tetrahydroisoquinoline derivatives
App 20030176415 - Aissaoui, Hamed ;   et al.
2003-09-18
6 alkoxy-4-pyrimidinyl bis-sulfonamides
Grant 6,596,719 - Bolli , et al. July 22, 2
2003-07-22
Butyne diol derivatives
App 20030087920 - Bolli, Martin ;   et al.
2003-05-08
Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
Grant 6,133,442 - Breu , et al. October 17, 2
2000-10-17
Sulfonamides
Grant 6,004,965 - Breu , et al. December 21, 1
1999-12-21
Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
Grant 5,962,682 - Breu , et al. October 5, 1
1999-10-05
Sulfonylaminopyrimidine carboxylic acid derivatives having endothelin inhibiting activity
Grant 5,856,484 - Breu , et al. January 5, 1
1999-01-05
Sulphonamides
Grant 5,837,708 - Breu , et al. November 17, 1
1998-11-17
Sulfonylaminopyrimidines
Grant 5,541,186 - Breu , et al. July 30, 1
1996-07-30
Phenylsulfonylamide pyrimidine
Grant 5,420,129 - Breu , et al. May 30, 1
1995-05-30
Sulfonamides
Grant 5,292,740 - Burri , et al. March 8, 1
1994-03-08
Sulfonamides and uses
Grant 5,270,313 - Burri , et al. December 14, 1
1993-12-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed